Wilson Sonsini Goodrich & Rosati advised Obsidio on the deal, while Latham & Watkins represented Boston Scientific Corporation. Boston Scientific Corporation announced the acquisition of Obsidio, Inc.,...
Boston Scientific’s Acquisition of Obsidio
Gallium Studios’ $6 Million Funding Round
The Wilson Sonsini team advised Gallium on the deal. Gallium Studios, an independent game studio founded by video game designers Will Wright (The Sims, SimCity, Spore) and...
Lumentum’s Acquisition of IPG Photonic’s Telecom Transmission Product Lines
Wilson Sonsini Goodrich & Rosati and Bronstein, Zilberberg, Chueiri e Potenza Advogados advised Lumentum. Locke Lord advised IPG Photonics in the transaction. Lumentum Holdings Inc. announced...
Gilead Sciences’ $405 Million Acquisition of MiroBio
Davis Polk & Wardwell, Mayer Brown, and Mishcon de Reya advised Gilead, while Goodwin Procter and Wilson Sonsini Goodrich & Rosati advised MiroBio on the deal....
BorgWarner’s Acquisition of Rhombus Energy
Wilson Sonsini advised Investors while Mintz, Levin, Cohn, Ferris, Glovsky and Popeo represented Rhombus Energy Solutions. BorgWarner inc. (BWA), an automotive supplier, announced it has acquired...
Future Health Works’ Partnership with HOPCo
Wilson Sonsini advised Future Health Works on the deal. Healthcare Outcomes Performance Company (HOPCo), a U.S. leader in musculoskeletal (MSK) physician practice management, outcomes management, and...
Kizik’s $20 Million Series B Round
Wilson Sonsini advised The Newcastle Network on the deal. Kizik, a leader in hands-free shoes, and its parent, HandsFree Labs, announced the completion of a $20...
Replay’s $55 Million Seed Funding
Wilson Sonsini advised Replay on the deal. Replay, a genome writing company reprogramming biology by writing and delivering big DNA, announced its launch with $55 million...
BigHat’s $75 Million Series B Financing
Gunderson Dettmer represented client Section 32 on the deal while Wilson Sonsini advised BigHat Biosciences. Section 32, a venture capital fund that invests in frontiers of...
Verve Therapeutics’ $225 Million Shares Public Offering
Wilson Sonsini Goodrich & Rosati advised Verve Therapeutics on the deal. Verve Therapeutics, a biotechnology company pioneering a new approach to the care of cardiovascular disease...
Faeth Therapeutics’ $47 Million Series A Financing
Wilson Sonsini advised Faeth Therapeutics on the deal. Faeth Therapeutics, a cancer metabolism company, announced the completion of a Series A financing of $47 million led...
SingleStore’s US$116 Million Investment Round
Sidley represented Goldman Sachs Asset Management on the deal while Wilson Sonsini advised SingleStore. Goldman Sachs Asset Management led a US$116M investment round in cloud-native database SingleStore....